Edwards Lifesciences (EW) Enterprise Value (2009 - 2026)

Edwards Lifesciences' Enterprise Value history runs 18 years deep, the most recent figure standing at -$3.7 billion for Q1 2026.

• In Q1 2026, Enterprise Value rose 4.28% year-over-year to -$3.7 billion; the TTM figure through Mar 2026 stood at -$3.7 billion (up 4.28% YoY), while the FY2025 annual figure was -$4.2 billion, down 8.05% from the prior year.
• Enterprise Value was -$3.7 billion for Q1 2026 at Edwards Lifesciences, up from -$4.2 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$1.2 billion in Q1 2023 to a low of -$4.4 billion in Q3 2024.
• Historically, Enterprise Value has averaged -$2.5 billion across 5 years, with a median of -$1.8 billion in 2023.
• The sharpest annual moves came in 2023 and 2024: Enterprise Value advanced 21.77% in 2023, then sank 150.19% in 2024.
• A 5-year view of Enterprise Value shows it stood at -$1.2 billion in 2022, then fell by 29.44% to -$1.6 billion in 2023, then tumbled by 150.19% to -$3.9 billion in 2024, then decreased by 8.05% to -$4.2 billion in 2025, then gained by 13.13% to -$3.7 billion in 2026.
• The last three Enterprise Value figures came in at -$3.7 billion (Q1 2026), -$4.2 billion (Q4 2025), and -$3.8 billion (Q3 2025), per Business Quant data.